PEDF: An endogenous factor displaying potent neuroprotective, neurotrophic, and antiangiogenic activity;PEDF - endogenny czynnik o silnym działaniu neuroprotekcyjnym, neurotroficznym i antyangiogennym

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 387-396

  Marciniak, Katarzyna ^a   Butwicka, Agnieszka ^a   Nowak, Jerzy Z ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antiangiogenic effect; Neuroprotection; Neurotrophic effect; PEDF; Pigment epithelium derived factor; Therapeutic potential

Indexed keywords

ANTINEOPLASTIC AGENT; EYE PROTEIN; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; PIGMENT EPITHELIUM DERIVED FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DRUG EFFECT; EYE; HUMAN; KIDNEY; LIVER; LUNG; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; RETINOBLASTOMA; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; ENGLISH ABSTRACT; EYE; EYE PROTEINS; HUMANS; KIDNEY; LIVER; LUNG; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; RETINOBLASTOMA; SERPINS;

EID: 33846040365     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Alberdi E., Aymerich M.S., Becerra S.P.: Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor. J. Biol. Chem., 1999; 274: 31605-31612
2. Araki T., Taniwaki T., Becerra S.P., Chader G.J., Schwarz J.P.: Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J. Neurosci. Res., 1998; 53: 7-15
3. Aymerich M.S., Alberdi E.M., Martinez A., Becerra S.P.: Evidence for pigment epithelium-derived factor receptors in the neural retina. Invest. Ophthalmol. Vis. Sci., 2001; 42: 3287-3293
4. Barnstable C., Tombran-Tink J.: Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential, Prog. Retin Eye Res., 2004; 23: 561-577
5. Becerra S.P., Sagasti A., Spinella P., Notario V.: Pigment epitheliumderived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J. Biol. Chem., 1995; 270: 25992-25999
6. Bilak M.M., Becerra S.P., Vincent A.M., Moss B.H., Aymerich M.S., Kuncl R.W.: Identification of neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J. Neurosci., 2002; 22: 9378-9386
7. Bilak M.M., Corse A.M., Bilak S.R., Lehar M., Tombran-Tink J., Kuncl R.W.: Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J. Neuropathol. Exp. Neurol., 1999; 58: 719-728
8. Bouck N.: PEDF: anti-angiogenic guardian of ocular function. Trends Mol. Med., 2002; 8: 330-334
9. Campochiaro P.A.: Retinal and choroidal neovascularization. J. Cell Physiol., 2000; 184: 301-310
10. Campochiaro P.A., Nguyen Q.D., Shah S.M., Klein M.L., Holz E., Frank R.N., Saperstein D.A., Gupta A., Stout J.T., Macko J., DiBartolomeo R., Wei L.L.: Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum. Gene Ther., 2006; 17: 167-176
11. Cai J., Jiang W.G., Grant M.B., Boulton M.: Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of VEGFR-1. J. Biol. Chem., 2006; 281: 3604-3613
12. Cai J., Parr C, Watkins G., Jiang W.G., Boulton M.: Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin. Cancer Res., 2006; 12: 3510-3517
13. Cao W., Tombran-Tink J., Chen W., Mrazek D., Elias R., McGinnis J.F.: Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J. Neurosci. Res. 1999; 57: 789-800
14. Cao W., Tombran-Tink J., Elias R., Sezate S., Mrazek D., Mc Ginnis J.F.: In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci., 2001; 42: 1646-1652
15. Carrell R.W., Pemberton P.A., Boswell D.R.: The serpins: evolution and adaptation in a family of protease inhibitors. Cold Spring Harb. Symp. Quant. Biol., 1987; 52: 527-535
16. Cayouette M., Smith S.B., Becerra S.P., Gravel C.: Pigment epitheliumderived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol. Dis., 1999; 6: 523-532
17. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., Bouck N.P.: Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science, 1999; 285: 245-248
18. DeCoster M.A., Schabelman E., Tombran-Tink J., Bazan N.G.: Neuroprotection by pigment epithelium-derived factor against glutamate toxicity in developing primary hippocampal neurons. J. Neurosci. Res., 1999; 56: 604-610
19. Doll J.A., Stellmach V.M., Bouck N.P., Bergh A.R., Lee C., Abramson L.P., Cornwell M.L., Pins M.R., Borensztajn J., Crawford S.E.: Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med., 2003; 9: 774-780
20. Ferrara N.: Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin. Oncol., 2002; 29: 10-14
21. Folkman J.: Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 2002; 29: 15-18
22. Funatsu H., Yamashita H., Nakamura S., Mimura T., Eguchi S., Noma H., Hori S.: Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology, 2006; 113: 294-301
23. Goliath R., Shugart Y.Y., Janssens P., Weissenbach J., Beighton P., Rameser R., Greenberg J.: Fine localization of the locus for autosomal dominant retinitis pigmentosa on chromosome 17p. Amer. J. Hum. Genet., 1995; 57: 962-965
24. Goliath R., Tombran-Tink J., Rodriquez I.R., Chader G., Ramesar R., Greenberg J.: The gene for PEDF, a retinal growth factor is a prime candidate for retinitis pigmentosa and is tightly linked to the RP13 locus on chromosome 17p13.3. Mol. Vis., 1996; 2: 5
25. Greenberg J., Goliath R., Beighton P., Ramesar R.: A new locus for autosomal dominant retinitis pigmentosa on the short arm of chromosome 17. Hum. Mol. Genet., 1994; 3: 915-918
26. Griffioen A.W., Molema G.: Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev., 2000; 52: 237-268
27. Guan M., Pang C.P., Yam H.F., Cheung K.F., Liu W.W., Lu Y.: Inhibition of glioma invasion by overexpression of pigment epithelium derivedfactor. Cancer Gene Ther., 2004; 11: 325-332
28. Hase R., Miyamoto M., Uechara H., Kadoya M., Ebihara Y., Murakami Y., Takahashi R., Mega S., Li L., Shichinohe T., Kawarada Y., Kondo S.: Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin. Cancer Res., 2005; 11: 8737-8744
29. Hivert B., Cerruti C., Camu W.: Hydrogen peroxide-induced motoneuron apoptosis is prevented by poly ADP ribosyl synthetase inhibitors. Neuroreport, 1998; 9: 1835-1838
30. Hjelmeland L.M., Cristofolo V.J., Funk W., Rakoczy E., Katz M.L.: Senescence of the retinal pigment epithelium. Mol. Vis., 1999; 5: 33
31. Holekamp N.M., Bouck N., Volpert O.: Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am. J. Ophthalmol., 2002; 134: 220-227
32. Houenou L.J., D'Costa A.P., Li L., Turgeon V.L., Enyadike C., Alberdi E., Becerra S.P.: Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol., 1999; 412: 506-514
33. Hutchings H., Maitre-Boube M., Tombran-Tink J., Plouet J.: Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes. Biochem. Biophys. Res. Commun., 2002; 294: 764-769
34. Jablonski M.M., Tombran-Tink J., Mrazek D.A., Iannaccone A.: Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal. J. Neurosci., 2000; 20: 7149-7157
35. Jablonski M.M., Tombran-Tink J., Mrazek D.A., Iannaccone A.: Pigment epithelium-derived factor supports normal Mûller cell development and glutamine synthetase expression after removal of the retinal pigment epithelium. Glia, 2001; 35: 14-25
36. Karakousis P.C., John S.K., Behling K.C., Surace E.M., Smith J.E., Hendrickson A., Tang W.X., Bennett J., Milam A.H.: Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol. Vis., 2001; 7: 154-163
37. Klegeris A., McGeer P.L.: Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicity. Glia, 2005; 51: 56-64
38. Liu H., Ren J.G., Cooper W.L., Hawkins C.E., Cowan M.R., Tong P.Y.: Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc. Natl. Acad. Sci. USA, 2004; 101: 6605-6610
39. Malchiodi-Albedi F., Feher J., Caiazza S., Formisano G., Perilli R., Falchi M., Petrucci T.C., Scorcia G., Tombran-Tink J.: PEDF (pigment epithelium-derived factor) promotes increase and maturation of pigment granules in pigment epithelial cells in neonatal albino rat retinal cultures. Int. J. Dev. Neurosci., 1998; 16: 423-432
40. Marshall C.J.: Evolutionary relationships among the serpins. Invest. Ophtalmol. Visual Sci., 1986; 27: 1760-1764
41. McGeer P.L., McGeer E.G.: Inflammation and the degenerative diseases of aging. Ann. NY Acad. Sci., 2004; 1035: 104-116
42. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack D.J., Li Q., Berns K.I., Raisler B.J., Hauswirth W.W., Campochiaro P.A.: AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 2002; 43: 1994-2000
43. Nowak J.Z.: Czynnik pochodzacy z nablonka barwnikowego (PEDF)-potencjal neuroprotekcyjny, neurotroficzny i rola w regulacji angiogenezy. Zimowa Szkola Instytutu Farmakologii PAN, 2003; 20: 217-227
44. Nowak J.Z.: Wartosæ diagnostyczna poziomów VEGF i PEDF dla oceny procesu neowaskularyzacyjnego w chorobach oczu. Okulistyka, 2004; 2: 49-54
45. Nowak J.Z., Wiktorowska-Owczarek A.: Neowaskularyzacja w tkankach oka: mechanizmy i rola czynników pro-i antyangiogennych. Klinika Oczna, 2004; 106: 90-97
46. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., Matsumura M., Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am. J. Ophthalmol., 2002; 134: 348-353
47. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., Matsumura M.: Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rheumatogenous retinal detachment and proliferative vitreoretinopathy. Am. J. Ophthalmol., 2002; 133: 851-852
48. Ogata N., Wang L., Jo N., Tombran-Tink J., Takahashi K., Mrazek D., Matsumura M.: Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr. Eye Res., 2001; 22: 245-252
49. Ortego J., Escribano J., Becerra S.P., Coca-Prados M.: Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor. Invest. Ophthalmol. Vis. Sci., 1996; 37: 2759-2767
50. Palmieri D., Watson J.M., Rinehart C.A.: Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence. Exp. Cell. Res., 1999; 247: 142-147
51. Perez-Mediavilla L.A., Chew C., Campochiaro P.A., Nickells R.W., Notario V., Zack D.J., Becerra S.P.: Sequence and expression analysis of bovine pigment epithelium-derived factor. Biochem. Biophys. Act., 1998; 1398: 203-214
52. Saishin Y., Silva R.L., Saishin Y., Kachi S., Aslam S., Gong Y.Y., Lai H., Carrion M., Harris B., Hamilton M., Wei L., Campochiaro P.A.: Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum. Gene Ther., 2005; 16: 473-478
53. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remolad-O'Donnell E., Salvesen G.S., Travis J., Whisstosck J.C.: The serpins are an expanding superfamilly of structurally similar but functionally diverse proteins. J. Biol. Chem., 2001; 276: 33293-33296
54. Singh V.K., Chader G.J., Rodriguez I.R.: Structural and comparative analysis of the mouse gene for pigment epithelium-derived factor (PEDF). Mol. Vis., 1998; 4: 7
55. Sondell M., Lundborg G., Kanje M.: Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci., 1999; 19: 5731-5740
56. Steele F.R., Chader G.J., Johnson L.V., Tombran-Tink J.: Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA, 1993; 90: 1526-1530
57. Sugita Y., Becerra S.P. Chader G.J. Schwartz J.P.: Pigment epitheliumderived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J. Neurosci. Res., 1997; 49: 710-718
58. Taniwaki T., Becerra S.P., Chader G.J., Schwartz J.P.: Pigment epithelium-derived factor is survival factor for cerebellar granule cells in culture. J. Neurochem., 1995; 64: 2509-2517
59. Taniwaki T., Hirashima N., Becerra S.P., Chader G.J., Etcheberrigaray R., Schwartz J.P.: Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J. Neurochem., 1997; 68: 26-32
60. Tombran-Tink J.: The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights in phylogeny, function and signaling. Front. Biosci., 2005; 10: 2131-2149
61. Tombran-Tink J., Chader G.J., Johnson L.V.: PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res., 1991; 53: 411-414
62. Tombran-Tink J., Johnson L.V.: Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Visual Sci., 1989; 30: 1700-1707
63. Tombran-Tink J., Mazuruk K., Rodriguez I.R., Chung D., Linker T., Englander E., Chader G.J.: Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vis., 1996; 2: 11
64. Tombran-Tink J., Pawar H., Swaroop A., Rodriguez I., Chader G.J.; Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics, 1994; 19: 266-272
65. Tombran-Tink J., Shivaram S.M., Chader G.J., Johnson L.V., Bok D.: Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J. Neurosci., 1995; 15: 4992-5003
66. Volpert O.V., Zaichuk T., Zhou W., Reiher F., Ferguson T.A., Stuart P.M., Amin M., Bouck N.P.: Inducer-stimulated Fas targets activated endothelium for destrustion by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med., 2002; 8: 349-357
67. Wang L., Schmitz V., Perez-Mediavilla A., Izal I., Prieto J., Qian C.: Supression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium derived factor. Mol. Ther., 2003; 8: 72-79
68. Whisstock J.C., Pike R.N., Jin L., Skinner R., Pei X.Y., Carrell R.W., Lesk A.M.: Conformational changes in serpins: II. Mechanism of activation of antithrombin by heparindagger. J. Mol. Biol., 2000; 301: 1287-1305
69. Whisstock J.C., Skinner R., Lesk A.M.: An atlas of serpin confirmations. Trends Biochem. Sci., 1998; 23: 63-67
70. Wick A., Wick W., Waltenberger J., Weller M., Dichgans J., Schultz J.B.: Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci., 2002; 22, 6401-6407
71. Yabe T., Wilson D., Schwartz J.P.: NFkB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J. Biol. Chem., 2001; 276: 43313-43319
72. Yamagishi S., Amano S., Inagaki Y., Okamoto T., Takeuchi M., Inoue H.: Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc. Res., 2003; 65: 186-190